|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-11-10
|
|
pubmed:abstractText |
We assessed the effectiveness of cetuximab plus chronomodulated irinotecan, 5-fluorouracil (5-FU), leucovorin (FA) and oxaliplatin (L-OHP) (chrono-IFLO) administered as neoadjuvant chemotherapy to increase the resectability of colorectal liver metastases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Leucovorin,
http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/cetuximab,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan,
http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1532-1827
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
9
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1542-7
|
|
pubmed:dateRevised |
2011-11-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20959822-Adult,
pubmed-meshheading:20959822-Aged,
pubmed-meshheading:20959822-Antibodies, Monoclonal,
pubmed-meshheading:20959822-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20959822-Camptothecin,
pubmed-meshheading:20959822-Colorectal Neoplasms,
pubmed-meshheading:20959822-Diarrhea,
pubmed-meshheading:20959822-Disease-Free Survival,
pubmed-meshheading:20959822-Female,
pubmed-meshheading:20959822-Fluorouracil,
pubmed-meshheading:20959822-Hepatectomy,
pubmed-meshheading:20959822-Humans,
pubmed-meshheading:20959822-Leucovorin,
pubmed-meshheading:20959822-Liver Neoplasms,
pubmed-meshheading:20959822-Male,
pubmed-meshheading:20959822-Middle Aged,
pubmed-meshheading:20959822-Neoadjuvant Therapy,
pubmed-meshheading:20959822-Organoplatinum Compounds,
pubmed-meshheading:20959822-Receptor, Epidermal Growth Factor,
pubmed-meshheading:20959822-Research Design,
pubmed-meshheading:20959822-Survival Rate,
pubmed-meshheading:20959822-Tomography, X-Ray Computed
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial.
|
|
pubmed:affiliation |
Department of Medical Oncology, Regina Elena Cancer Institute, Rome, Italy. carlo.garufi@fastwebnet.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
